RALEIGH — A cardiovascular medical device company has raised $4.4 million in a private equity offering, according to a filing with the Securities and Exchange Commission.
Raleigh-based NuPulseCV Inc. raised the money from 13 investors, according to the filing. It is seeking to raise a total of $25 million.
NuPulseCV
The company ha 21 employees, according to its website.
According to Crunchbase, NuPulse has raised $21.3 million in earlier funding rounds.
The company is developing a novel, implantable pump to treat people suffering from congestive heart failure.
The device, which requires a minimally invasive surgery, provides patients an alternative to medical therapy.
NuPulse has a strategic and financial partnership with one of the leading heart failure companies in the world.
The company was founded in 2010 and originally based in Tucson, Arizona, but the SEC filing lists a Raleigh address. The president is Douglas Altschuler.
Altschuler has been chief executive officer, chief operating officer and general counsel for both private and publicly traded biotechnology companies. A law graduate of the University of Arizona, he has a track record of successful interactions with the Food and Drug Administration and leaders in the medical industry in the establishment of start-up companies.
Companies relying on a Reg D exemption do not have to register their offering of securities with the SEC, but they must file what’s known as a Form D electronically with the SEC after they first sell their securities.
This story is from the North Carolina Business News Wire, a service of the UNC-Chapel Hill School of Media and Journalism
